AIN
TEEREx

TEEREx

location_on Central ,  Switzerland

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

Transcatheter Edge-to-Edge Repair (TEER) can occasionally face challenges or "failures,". Transcatheter valve replacement offers an alternative. However needs to be removed for valve replacement.

Highlights

  • Unmet need: 20% TEER failures, no safe standardized removal tool
  • Unique tech: First dedicated mechanical device for clip extraction.
  • Big market: CHF 200–300M yearly, TEER growing 12% CAGR worldwide.
  • Strong traction: Patent, grants, SIPBB, UZH & sitem-insel and KOL partners.
  • High upside: FIH 2027, CHF 6–7M 2029, scalable pipeline, exit ready.

Overview

Target CA$ 850,000
Minimum CA$ 175,000
Investment Raised CA$ 0
Previous Rounds CA$ 0
Stage Pre-Startup/R&D
Investor Role Any

Ask a question
Got a question about this project?

Similar Projects